A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SOL-804 in Healthy Male Subjects
Condition: Prostate Cancer Interventions: Drug: SOL-804-F; Drug: Zytiga Sponsors: Bukwang Pharmaceutical; Dyna Therapeutics Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials